CeraVe Grew by Letting Dermatologists Do the Advertising

CeraVe was acquired by L'Oréal in 2017 for $1.3 billion when it had less than $200 million in annual sales. By 2026, trade reports put annual retail sales above $2.1 billion. That is a dramatic increase in roughly nine years, and almost none of the early growth came from the kind of advertising most marketing teams would recognize.

The brand didn't build a creative platform first. It didn't hire a celebrity. It didn't run a Super Bowl spot. It did something harder to copy: it earned the trust of dermatologists, and then let that trust do most of the work.

That is a specific strategic sequence, and understanding why it worked requires thinking about how memory and purchase decisions actually operate, not just how advertising is usually sold.

The Product Had to Earn the Recommendation First

CeraVe was founded in 2005 with a formulation built around ceramides, the lipids that make up a significant portion of the skin's natural barrier. That wasn't a marketing decision. It was a product decision that made the subsequent marketing possible.

Dermatologists don't recommend products as a favor. They recommend products that their patients tolerate well and that produce visible results. The brand's early growth was built almost entirely on dermatologist endorsement and office sampling, not mass advertising. CeraVe now has over 20 products recommended by the National Eczema Association, which is the kind of third-party validation you cannot buy with a media budget.

This is the part most brand analyses skip over. The CeraVe strategy is frequently described as a social media story, a TikTok story, or an influencer story. Those are all real chapters in the brand's history. But the first chapter was clinical credibility, and without it, nothing else holds.

What Dermatologist Credibility Actually Built

In Never Always, Never Never, Patrick Gilbert draws on Jenni Romaniuk's concept of category entry points to explain how brands get chosen. The idea is that purchase decisions are triggered by specific situations: hunger, a skin flare-up, a doctor's recommendation. The brand most strongly linked to that trigger in memory is most likely to be chosen.

For CeraVe, dermatologists were the trigger mechanism. A patient comes in with dry skin or eczema. The dermatologist recommends CeraVe by name. That recommendation doesn't just create a sale. It creates a mental availability link that is qualitatively different from anything an ad impression can produce, because it comes from a trusted authority in a high-stakes context.

Byron Sharp's research at the Ehrenberg-Bass Institute shows that mental availability, the probability a brand comes to mind in a buying situation, is shaped by the quantity and quality of memory structures connecting a brand to relevant cues. A dermatologist's recommendation is one of the highest-quality memory structures a skincare brand can build. It ties the brand to a cue (skin concern), a context (medical advice), and an emotion (relief, trust) all at once.

This is why competitors can't simply replicate the CeraVe model by spending more on marketing. They can buy media. They cannot quickly buy fifteen years of dermatologist adoption grounded in product performance.

Physical Availability Converted That Trust Into Revenue

Mental availability gets you considered. Physical availability gets you purchased.

L'Oréal's own description of the CeraVe acquisition emphasizes the full three-part model: firm dermatologist recommendations, wide physical distribution, and strong social media engagement. The distribution piece is not an afterthought. CeraVe is available across pharmacies, drugstores, large retailers, specialist stores, and online channels. When a patient leaves a dermatologist's office with a product recommendation, the brand is stocked at the CVS two blocks away, on the Walmart shelf, and on Amazon for next-day delivery.

This is the conversion layer. The recommendation creates desire. The distribution ensures that desire can become action without friction. Remove either half and the model breaks. A brand that earns strong clinical credibility but isn't easily available will lose the sale to a competitor that is. A brand that is widely distributed but lacks the underlying credibility recommendation will struggle to build mental availability at scale.

The physical availability marketing principle, covered in depth in the book, is that growth requires being easy to think of AND easy to buy. CeraVe executes both.

The TikTok Tailwind Was Real, but It Wasn't the Foundation

Around 2019 and 2020, the brand benefited from a wave of ingredient-literate skincare consumers on TikTok. Dermatologists and aestheticians with large followings started recommending CeraVe by name in videos about skincare routines, barrier repair, and eczema management. These creators amplified existing clinical credibility rather than inventing new credibility from scratch.

That distinction matters. Influencer marketing that works with pre-existing authority is structurally different from influencer marketing trying to manufacture it. The TikTok dermatologists weren't saying something new about CeraVe. They were repeating what office-based dermatologists had been saying for fifteen years, in a format that reached millions of light buyers who had never visited a dermatologist.

Sales rose 82% in the first nine months of 2020, during a period of surging skincare demand. The brand was well-positioned to capture that demand because the mental availability infrastructure was already built. L'Oréal's 2017 annual report had already called CeraVe "one of the fastest-growing skincare brands in the United States" before the TikTok wave arrived.

The platform amplified what was already there. It didn't create it.

The Michael CeraVe Campaign: Earned Media at Scale

In 2024, CeraVe ran one of the more structurally interesting Super Bowl campaigns in recent memory. The premise: actor Michael Cera appeared to have co-founded the brand, leading consumers to search whether dermatologists or a Canadian actor were responsible for CeraVe's development.

The execution was social-first. The campaign seeded content online for weeks before the 30-second Super Bowl spot aired. By the time it reached television, it had already generated 15.4 billion earned impressions before the TV reveal. Total campaign results, per the Shorty Awards entry, included 32 billion earned impressions, a 25% sales lift, the brand's highest-ever moisturizer sales week, over 2,000 articles, 5% audience growth, and a 1,350% increase in searches for who developed CeraVe.

That last metric is the most revealing. A 1,350% increase in searches for who developed CeraVe means the campaign drove an enormous number of people to actively investigate the brand's origins. The answer they found, that dermatologists developed it, reinforced the exact mental association that built the brand in the first place. The stunt was funny. But the strategic payload was the reminder that doctors, not celebrities, are behind the product.

This is what Never Always, Never Never describes when discussing emotional advertising effectiveness: emotion doesn't have to look like sentimentality. Sometimes it looks like humor and earned media. The Michael CeraVe campaign made people laugh, made them curious, and then handed them a conclusion that strengthened the brand's core positioning. That is emotional advertising in a less obvious form.

What the L'Oréal Active Cosmetics Division Tells Us

CeraVe sits in L'Oréal's Active Cosmetics division alongside La Roche-Posay and SkinCeuticals. Business of Fashion reported that Active Cosmetics was the only L'Oréal division with positive growth in the period studied, which puts the derm-validated skincare model in competitive context.

This isn't just a CeraVe story. It's a category story. The shift in skincare toward ingredient-focused, evidence-led, dermatologist-validated products has been building for years. The brand was early and deliberate in owning that positioning. By the time the broader market moved in that direction, it had a structural advantage that was hard to close quickly.

La Roche-Posay followed a similar model. SkinCeuticals went further upmarket. But CeraVe stayed affordable and broadly accessible, which kept physical availability high and purchase barriers low. The brand's positioning, as L'Oréal describes it, is "simple, effective and accessible." That is not an accident. Accessible means the product is attainable by the full range of consumers who might receive a dermatologist's recommendation, not just those who can afford a $60 serum.

What the CeraVe Model Actually Teaches

The CeraVe story is sometimes told as a social media strategy. It isn't. Social media was the amplification layer, and a real one, but it came third.

The actual sequence was:

• Product credibility earned through formulation and clinical performance
• Third-party authority built through dermatologist adoption and National Eczema Association recognition
• Mental availability created by linking the brand to high-stakes skin care moments via trusted voices
• Physical availability ensured through broad distribution so recommendation intent converted to purchase
• Amplification via creator content, TikTok tailwinds, and eventually a culturally resonant Super Bowl campaign

Brands that try to run this playbook in reverse, starting with the Super Bowl spot and hoping it creates the credibility, will find it doesn't work. The Michael CeraVe campaign landed because the underlying authority was real. The campaign confirmed what dermatologists had been saying for fifteen years. Without that foundation, the joke has no punchline.

The concept that Patrick Gilbert covers in Never Always, Never Never around brand salience is directly applicable here. Salience is the brand's share of people's minds, defined by the quantity and quality of memory links to and from the brand. CeraVe spent years building high-quality memory links through clinical channels before it built quantity through mass media. That is a defensible position. The quality came first.

At AdVenture Media, this sequencing question comes up constantly: brands want the reach before they've earned the authority. CeraVe is a useful counterargument.

The broader lesson for any brand considering a credibility-first strategy: third-party validation is only as durable as the product that earns it. The dermatologists didn't keep recommending CeraVe as a courtesy. They recommended it because patients responded well. The marketing story and the product story are the same story. That is rarer than it sounds, and it is exactly what makes the model hard to replicate.

For a brand considering how brand vs performance marketing applies to their own situation, this model offers a useful frame. The early investment in clinical credibility was functionally brand marketing, just without traditional media spend. The payoff showed up in purchase conversion rates, recommendation frequency, and eventually in the earned media value of campaigns that could make 32 billion impressions because the brand had something worth amplifying.

That is the full model. Not TikTok. Not Super Bowl. Credibility first, distribution second, amplification third.